Fatty acids as biocompounds: Their role in human metabolism, health and disease - a review. part 2: Fatty acid physiological roles and applications in human health and disease

Biomedical Papers

Volumn 155, Issue 3, 2011, Pages 195-218

  Kremmyda, Lefkothea Stella ^a   Tvrzicka, Eva ^a   Stankova, Barbora ^a   Zak, Ales ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cancer; Cardiovascular; Development; Fatty acids; Gene expression; Immunity; Lipid mediators

Indexed keywords

FATTY ACID;

ARTICLE; CHEMISTRY; FAT INTAKE; HEALTH CARE POLICY; HUMAN; PHYSIOLOGY;

DIETARY FATS; FATTY ACIDS; HUMANS; NUTRITION POLICY;

EID: 80054121197     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2011.052     Document Type: Article

References (269)

1. Crovetto M, Uauy R. Changes in household food and nutrient consumption in Metropolitan Santiago 1988-97 by income. Rev Med Chil 2010;138:1091-108.
2. Austin GL, Ogden LG, Hill JO. Trends in carbohydrate, fat, and protein intakes and association with energy intake in normal-weight, overweight, and obese individuals: 1971-2006. Am J Clin Nutr 2011; Epub ahead of print: (doi)10.3945/ajcn.110.000141.
3. Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr 2010;29:289S-301S.
4. Tvrzicka E, Kremmyda L-S, Stankova B, Zak A. Fatty acids as biocompounds: Their role in human metabolism, health and disease - A review. Part 1: classification, dietary sources and biological functions. Biomed Pap 2011;155:117-30.
5. Brenna JT, Salem N, Jr., Sinclair AJ, Cunnane SC. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009;80:85-91.
6. Lattka E, Illig T, Koletzko B, Heinrich J. Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 2010;21:64-9.
7. Merino DM, Ma DW, Mutch DM. Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids Health Dis 2010;9:63.
8. EFSA Panel on Dietetic Products, Nutrition and Allergens (NDA). Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal 2010;8:1461.
9. Nelson DL, Cox MM. Lipid Biosynthesis. In: Principles of Biochemistry. New York: W.H. Freeman and Company; 2005. p. 787-815.
10. Nelson DL, Cox MM. Lipids. In: Principles of Biochemistry. New York: W.H. Freeman and Company; 2005. p. 343-63.
11. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
12. Fukami K, Inanobe S, Kanemaru K, Nakamura Y. Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balance. Prog Lipid Res 2010;49:429-37.
13. Nishizuka Y. Membrane phospholipid degradation and protein kinase C for cell signalling. Neurosci Res 1992;15:3-5.
14. Smith WL. Nutritionally essential fatty acids and biologically in-dispensable cyclooxygenases. Trends Biochem Sci 2008;33:27-37.
15. Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004;39:1125-32.
16. Serhan CN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr Opin Clin Nutr Metab Care 2005;8:115-21.
17. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 2005;15:159-66.
18. Bazan NG, Calandria JM, Serhan CN. Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. J Lipid Res 2010;51:2018-31.
19. Oh SF, Pillai PS, Recchiuti A, Yang R, Serhan CN. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J Clin Invest 2011;121:569-81.
20. Bannenberg G, Serhan CN. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim Biophys Acta 2010;1801:1260-73.
21. Berdyshev EV, Boichot E, Lagente V. Anandamide--a new look on fatty acid ethanolamides. J Lipid Mediat Cell Signal 1996;15:49-67.
22. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2007;77:327-35.
23. Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003;38:343-52.
24. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002;21:495-505.
25. Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors 2009;35:266-72.
26. Haeggstrom JZ, Wetterholm A. Enzymes and receptors in the leukotriene cascade. Cell Mol Life Sci 2002;59:742-53.
27. Pratico D, Lawson JA, Rokach J, FitzGerald GA. The isoprostanes in biology and medicine. Trends Endocrinol Metab 2001;12:243-7.
28. Resh MD. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1999;1451:1-16.
29. The GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447-55.
30. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-61.
31. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-85.
32. Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY, Lupton JR. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr 2008;100:1152-7.
33. Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 2008;19:242-7.
34. Jump DB. Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care 2011;14:115-20.
35. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004;41:41-78.
36. Lapillonne A, Clarke SD, Heird WC. Polyunsaturated fatty acids and gene expression. Curr Opin Clin Nutr Metab Care 2004;7:151-6.
37. Pertwee RG. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 2008;13:147-59.
38. Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ. Biochemical markers of alcoholism. Clin Chem Lab Med 2007;45:953-61.
39. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993;292:617-29.
40. Engelstoft MS, Egerod KL, Holst B, Schwartz TW. A gut feeling for obesity: 7TM sensors on enteroendocrine cells. Cell Metab 2008;8:447-9.
41. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC, Crowley J, Yanagisawa M, Gordon JI. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 2008;105:16767-72.
42. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM. Glucose sensing in L cells: a primary cell study. Cell Metab 2008;8:532-9.
43. Bennett MV, Verselis VK. Biophysics of gap junctions. Semin Cell Biol 1992;3:29-47.
44. Lombardi F, Terranova P. Anti-arrhythmic properties of N-3 polyunsaturated fatty acids (n-3 PUFA). Curr Med Chem 2007;14:2070-80.
45. D-A-CH (Deutsche Gesellschaft für Ernährung - Österreichische Gesellschaft für Ernährung - Schweizerische Gesellschaft für Ernährungsforschung - Schweizerische Vereinigung für Ernährung). Referenzwerte für die Nährstoffzufuhr. Umschau Braus Verlag, Frankfurt am Main; 2008.
46. NNR (Nordic Nutrition Recommendations). Integrating nutrition and physical activity. Copenhagen: Nordic Council of Ministers; 2004.
47. Department of Health (UK). Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London: HMSO; 1991.
48. AFSSA (Agence Française de Sécurité Sanitaire des Aliments). Apports nutritionnels conseillés pour la population française. Paris: Editions Tec&Doc; 2001.
49. GR (Gezondheidsraad). Dietary Reference Intakes: energy, proteins, fats and digestible carbohydrates. The Hague: Health Council of the Netherlands; 2001.
50. HHS/USDA. Dietary Guidelines for Americans. US Department of Health and Human Services/US Department of Agriculture; 2005.
51. WHO/FAO (World Health Organization/Food and Agriculture Organization). Interim Summary of Conclusions and Dietary Recommendations on Total Fat & Fatty Acids. Geneva: The Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition; 2008.
52. NCEP (National Cholesterol Education Program). Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). National Institutes of Health (USA); 2001: Publication No 01-3670.
53. Cetin I, Koletzko B. Long-chain omega-3 fatty acid supply in pregnancy and lactation. Curr Opin Clin Nutr Metab Care 2008;11:297-302.
54. Simopoulos AP, Leaf A, Salem NJ. Workshop on the essentiality of and Recommended Dietary Intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 1999;18:487-9.
55. Koletzko B, Cetin I, Brenna JT. Dietary fat intakes for pregnant and lactating women. International Society for the Study of Fatty Acids and Lipids Newsletter 2007;14:12-7.
56. SACN (Scientific Advisory Committee on Nutrition, Committee on Toxicity). Advice on fish consumption: benefits and risks. London: The Stationary Office; 2004.
57. NHMRC (National Health and Medical Research Council). Dietary Guidelines for Australian Adults. Canberra; 2003.
58. Smit LA, Mozaffarian D, Willett W. Review of fat and fatty acid requirements and criteria for developing dietary guidelines. Ann Nutr Metab 2009;55:44-55.
59. Elmadfa I, Kornsteiner M. Fats and fatty acid requirements for adults. Ann Nutr Metab 2009;55:56-75.
60. Gluckman PD, Hanson MA, Mitchell MD. Developmental origins of health and disease: reducing the burden of chronic disease in the next generation. Genome Med 2010;2:14.
61. Jackson AA, Burdge GC, Lillycrop KA. Diet, nutrition and modulation of genomic expression in fetal origins of adult disease. World Rev Nutr Diet 2010;101:56-72.
62. Barker DJ. The origins of the developmental origins theory. J Intern Med 2007;261:412-7.
63. Allan K, Kelly FJ, Devereux G. Antioxidants and allergic disease: a case of too little or too much? Clin Exp Allergy 2009;40:370-80.
64. Department of Health (UK), Food Standards Agency. National Diet and Nutrition Survey: NDNS Headline results from Year 1 of the Rolling programme (2008/2009). London: The Stationary Office; 2009.
65. Shaheen SO, Newson RB, Henderson AJ, Emmett PM, Sherriff A, Cooke M. Umbilical cord trace elements and minerals and risk of early childhood wheezing and eczema. Eur Respir J 2004;24:292-7.
66. Jennings S, Prescott SL. Early dietary exposures and feeding practices: role in pathogenesis and prevention of allergic disease? Postgrad Med J 2010;86:99.
67. Prescott SL, Dunstan JA. Prenatal fatty acid status and immune development: The pathways and the evidence. Lipids 2007;42:801-10.
68. Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 2000;54:S47-S51.
69. Herrera E, Lopez-Soldado I, Limones M, Amusquivar E, Ramos MP. Lipid metabolism during the perinatal phase, and its implications on postnatal development. Int J Vit Nutr Res 2006;76:216-24.
70. Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 2002;19:43-55.
71. Haggarty P. Effect of placental function in fatty acid requirements during pregnancy. Eur J Clin Nutr 2004;58:1559-70.
72. Klingler M, Demmelmair H, Larque E, Koletzko B. Analysis of FA contents in individual lipid fractions from human placental tissue. Lipids 2003;38:561-6.
73. Herrera E, Amusquivar E, Lopez-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res 2006;65:S59-S64.
74. Hanebutt FL, Demmelmair H, Schiessl B, Larque E, Koletzko B. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin Nutr 2008;27:685-93.
75. Bitsanis D, Crawford MA, Moodley T, Holmsen H, Ghebremeskel K, Djahanbakhch O. Arachidonic acid predominates in the membrane phosphoglycerides of the early and term human placenta. J Nutr 2005;135:2566-71.
76. Khan AH, Carson RJ, Nelson SM. Prostaglandins in labor--a translational approach. Front Biosci 2008;13:5794-809.
77. Berghaus TM, Demmelmair H, Koletzko B. Fatty acid composition of lipid classes in maternal and cord plasma at birth. Eur J Pediatr 1998;157:763-8.
78. De Vriese SR, Dhont M, Christophe AB. FA composition of cholesteryl esters and phospholipids in maternal plasma during pregnancy and at delivery and in cord plasma at birth. Lipids 2003;38:1-7.
79. Min Y, Ghebremeskel K, Crawford MA, Nam JH, Kim A, Koo JN, Suzuki H. Pregnancy reduces arachidonic and docosahexaenoic in plasma triacylglycerols of Korean women. Int J Vit Nutr Res 2000;70:70-5.
80. Vlaardingerbroek H, Hornstra G. Essential fatty acids in erythrocyte phospholipids during pregnancy and at delivery in mothers and their neonates: Comparison with plasma phospholipids. Prostaglandins Leukot Essent Fatty Acids 2004;71:363-74.
81. Houwelingen ACV, Foreman V, Nicolini U, Nicolaides KH, Al MDM, Kester ADM, Hornstra G. Essential fatty acid status of fetal plasma phospholipids: Similar to postnatal values obtained at comparable gestational ages. Early Hum Dev 1996;46:141-52.
82. De Vriese SR, Matthys C, De HS, De BG, Dhont M, Christophe AB. Maternal and umbilical fatty acid status in relation to maternal diet. Prostaglandins Leukot Essent Fatty Acids 2002;67:389-96.
83. Donahue SMA, Rifas-Shiman SL, Olsen SF, Gold DR, Gillman MW, Oken E. Associations of maternal prenatal dietary intake of n-3 and n-6 fatty acids with maternal and umbilical cord blood levels. Prostaglandins Leukot Essent Fatty Acids 2009;80:289-96.
84. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr 2000;71:1262S-9S.
85. Houwelingen AC, Ham ECH, Hornstra G. The female docosahexaenoic acid status related to the number of completed pregnancies. Lipids 1999;34:S229.
86. Bo S, Menato G, Lezo A, Signorile A, Bardelli C, De MF, Massobrio M, Pagano G. Dietary fat and gestational hyperglycaemia. Diabetologia 2001;44:972-8.
87. Oken E, Ning Y, Rifas-Shiman SL, Rich-Edwards JW, Olsen SF, Gillman MW. Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann Epidemiol 2007;17:663-8.
88. Al MDM, van Houwelingen AC, Hornstra G. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr 2000;71:285S-91S.
89. Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008;93:F45-F50.
90. Oken E, Kleinman KP, Olsen SF, Rich-Edwards JW, Gillman MW. Associations of seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results from a US pregnancy cohort. Am J Epidemiol 2004;160:774-83.
91. Olsen SF, Hansen HS, Sorensen TI, Jensen B, Secher NJ, Sommer S, Knudsen LB. Intake of marine fat, rich in (n-3)-polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 1986;2:367-9.
92. Olsen SF, Secher NJ. Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. BMJ 2002;324:447.
93. Olsen SF, Osterdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. Eur J Clin Nutr 2007;61:976-85.
94. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG 2000;107:382-95.
95. Dirix CE, Kester AD, Hornstra G. Associations between neonatal birth dimensions and maternal essential and trans fatty acid contents during pregnancy and at delivery. Br J Nutr 2009;101:399-407.
96. Horvath A, Koletzko B, Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr 2007;98:253-9.
97. Szajewska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006;83:1337-44.
98. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 2006;3:CD003402.
99. Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res 2008;1237:35-43.
100. Innis SM. Essential fatty acids in growth and development. Prog Lipid Res 1991;30:39-103.
101. Crawford MA, Hassam AG, Williams G. Essential fatty acids and fetal brain growth. Lancet 1976;1:452-3.
102. Koletzko B, Rodriguez-Palmero M. Polyunsaturated fatty acids in human milk and their role in early infant developement. J Mammary Gland Biol Neoplasia 1999;4:269-84.
103. Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, Jimenez M, Gil A, Rivero M, Veszpremi B, Decsi T, Koletzko BV. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: A European randomized multicenter trial. Am J CLin Nutr 2007;85:1392-400.
104. Houwelingen AC, Sorensen JD, Hornstra G, Simonis MMG, Boris J, Olsen SF, Secher NJ. Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. Br J Nutr 1995;74:723-31.
105. Malcolm CA, McCulloch DL, Montgomery C, Shepherd A, Weaver LT. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed 2003;88:F383-F390.
106. Judge MP, Harel O, Lammi-Keefe CJ. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am J Clin Nutr 2007; 85:1572-7.
107. Gibson RA, Neumann MA, Makrides M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 1997;51:578-84.
108. Jensen CL, Voigt RG, Llorente AM, Peters SU, Prager TC, Zou YL, Rozelle JC, Turcich MR, Fraley JK, Anderson RE, Heird WC. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatr 2010;157:900-5.
109. Lauritzen L, Jorgensen MH, Olsen SF, Straarup EM, Michaelsen KF. Maternal fish oil supplementation in lactation: Effect on developmental outcome in breast-fed infants. Reprod Nutr Dev 2005;45:535-47.
110. Lauritzen L, Jorgensen MH, Mikkelsen TB, Skovgaard IM, Straarup E-M, Olsen SF, Hoy C-E, Michaelsen KF. Maternal fish oil supplementation in lactation: Effect on visual acuity and omega-3 fatty acid content of infant erythrocytes. Lipids 2004;39:195-206.
111. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003;111:E39-E44.
112. Helland IB, Smith L, Blomen B, Saarem K, Saugstad OD, Drevon CA. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 2008;122:E472-E479.
113. Brenna JT, Lapillonne A. Background paper on fat and fatty acid requirements during pregnancy and lactation. Ann Nutr Metab 2009;55:97-122.
114. Lauritzen L, Kjaer TM, Porsgaard T, Fruekilde MB, Mu H, Frokiaer H. Maternal Intake of Fish Oil but not of Linseed Oil Reduces the Antibody Response in Neonatal Mice. Lipids 2011;46:171-8.
115. Oddy WH, Pal S, Kusel MMH, Vine D, De Klerk NH, Hartmann P, Holt PG, Sly PD, Burton PR, Stanley FJ, Landau LI. Atopy, eczema and breast milk fatty acids in a high-risk cohort of children followed from birth to 5 years. Pediatr Allergy Immunol 2006;17:4-10.
116. Stoney RM, Woods RK, Hosking CS, Hill DJ, Abramson MJ, Thien FCK. Maternal breast milk long-chain omega-3 fatty acids are associated with increased risk of atopy in breastfed infants. Clin Exp Allergy 2004;34:194-200.
117. Calder PC. Early life programming of immune and lung function: can we now exclude a role of arachidonic acid exposure? Br J Nutr 2009;102:331-3.
118. Calder PC, Kremmyda LS, Vlachava M, Noakes PS, Miles EA. Is there a role for fatty acids in early life programming of the immune system? Proc Nutr Soc 2010;69:373-80.
119. Kremmyda LS, Vlachava M, Noakes PS, Diaper ND, Miles EA, Calder PC. Atopy Risk in Infants and Children in Relation to Early Exposure to Fish, Oily Fish, or Long-Chain Omega-3 Fatty Acids: A Systematic Review. Clin Rev Allergy Immunol 2009; Epub ahead of print: (doi) 10.1007/s12016-009-8186-2.
120. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: A randomized, controlled trial. J Allergy Clin Immunol 2003;112:1178-84.
121. Furuhjelm C, Warstedt K, Larsson J, Fredriksson M, Fageras Bottcher M, Falth-Magnusson K, Duchen K. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatr 2009;98:1461-7.
122. Lauritzen L, Hoppe C, Straarup EM, Michaelsen KF. Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatr Res 2005;58:235-42.
123. Warstedt K, Furuhjelm C, Duchen K, Falth-Magnusson K, Fageras M. The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatr Res 2009;2:212-7.
124. Noakes PS, Hale J, Thomas R, Lane C, Devadason SG, Prescott SL. Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses. Eur Respir J 2006;28:721-9.
125. Noakes PS, Taylor P, Wilkinson S, Prescott SL. The relationship between persistent organic pollutants in maternal and neonatal tissues and immune responses to allergens: A novel exploratory study. Chemosphere 2006;63:1304-11.
126. Dunstan JA, Mitoulas LR, Dixon G, Doherty DA, Hartmann PE, Simmer K, Prescott SL. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatr Res 2007;62:689-94.
127. Bergmann RL, Haschke-Becher E, Klassen-Wigger P, Bergmann KE, Richter R, Dudenhausen JW, Grathwohl D, Haschke F. Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants. Ann Nutr Metab 2008;52:157-66.
128. Makrides M, Neumann MA, Gibson RA. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 1996;50:352-7.
129. Lauritzen L, Jorgensen MH, Hansen HS, Michaelsen KF. Fluctuations in human milk long-chain PUFA levels in relation to dietary fish intake. Lipids 2002;37:237-44.
130. Jensen CL, Maude M, Anderson RE, Heird WC. Effect of docosa-hexaenoic acid supplementation of lactating women on the fatty acid composition of breast milk lipids and maternal and infant plasma phospholipids. Am J Clin Nutr 2000;71:S292-S299.
131. Aitchison JM, Dunkley WL, Canolty NL, Smith LM. Influence of diet on trans fatty acids in human milk. Am J Clin Nutr 1977;30:2006-15.
132. Craig-Schmidt MC, Weete JD, Faircloth SA, Wickwire MA, Livant EJ. The effect of hydrogenated fat in the diet of nursing mothers on lipid composition and prostaglandin content of human milk. Am J Clin Nutr 1984;39:778-86.
133. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979;3:79-83.
134. Anderson JW, Johnstone BM, Remley DT. Breast-feeding and cognitive development: a meta-analysis. Am J Clin Nutr 1999;70:525-35.
135. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129-S138.
136. Jensen RG. Lipids in human milk. Lipids 1999;34:1243-71.
137. Uauy R, Dangour AD. Fat and fatty acid requirements and recommendations for infants of 0-2 years and children of 2-18 years. Ann Nutr Metab 2009;55:76-96.
138. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr 2007;85:1457-64.
139. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast-and formula-fed infants. Am J Clin Nutr 1994;60:189-94.
140. Tanaka K, Kon N, Ohkawa N, Yoshikawa N, Shimizu T. Does breastfeeding in the neonatal period influence the cognitive function of very-low-birth-weight infants at 5 years of age? Brain Dev 2009;31:288-93.
141. Innis SM, Gilley J, Werker J. Are human milk long-chain polyun-saturated fatty acids related to visual and neural development in breast-fed term infants? J Pediatr 2001;139:532-8.
142. Jorgensen MH, Hernell O, Hughes E, Michaelsen KF. Is there a relation between docosahexaenoic acid concentration in mothers' milk and visual development in term infants? J Pediatr Gastroenterol Nutr 2001;32:293-6.
143. Jensen CL, Voigt RG, Prager TC, Zou YL, Fraley JK, Rozelle JC, Turcich MR, Llorente AM, Anderson RE, Heird WC. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr 2005;82:125-32.
144. Kankaanpaa P, Nurmela K, Erkkila A, Kalliomaki M, Holmberg- Marttila D, Salminen S, Isolauri E. Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy: Allergy 2001;56:633-8.
145. Thijs C, Van HA, Poorterman I, Mordant A, Van Den BP. Essential fatty acids in breast milk of atopic mothers: Comparison with non-atopic mothers, and effect of borage oil supplementation. Eur J Clin Nutr 2000;54:234-8.
146. Lauritzen L, Kjaer TMR, Fruekilde M-B, Michaelsen KF, Frokiaer H. Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children. Lipids 2005;40:669-76.
147. Krauss-Etschmann S, Hartl D, Rzehak P, Heinrich J, Shadid R, Del C-T, Campoy C, Pardillo S, Schendel DJ, Decsi T, Demmelmair H, Koletzko BV, Nutraceuticals for Healthier Life Study Group. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. J Allergy Clin Immunol 2008;121:464-70.
148. Nwaru BI, Erkkola M, Ahonen S, Kaila M, Lumia M, Prasad M, Haapala AM, Kronberg-Kippila C, Veijola R, Ilonen J, Simell O, Knip M, Virtanen SM. Maternal diet during lactation and allergic sensitization in the offspring at age of 5. Pediatr Allergy Immunol 2011; Epub ahead of print: (doi) 10.1111/j.13993038.2010.01114.x.
149. Damsgaard CT, Lauritzen L, Kjaer TMR, Holm PMI, Fruekilde M-B, Michaelsen KF, Frokiaer H. Fish oil supplementation modulates immune function in healthy infants. J Nutr 2007;137:1031-6.
150. Nafstad P, Nystad W, Magnus P, Jaakkola JJ. Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy. J Asthma 2003;40:343-8.
151. Kull I, Bergstrom A, Lilja G, Pershagen G, Wickman M. Fish consumption during the first year of life and development of allergic diseases during childhood. Allergy 2006;61:1009-15.
152. Marks GB, Mihrshahi S, Kemp AS, Tovey ER, Webb K, Almqvist C, Ampon RD, Crisafulli D, Belousova EG, Mellis CM, Peat JK, Leeder SR. Prevention of asthma during the first 5 years of life: A randomized controlled trial. J Allergy Clin Immunol 2006;118:53-61.
153. Birch EE, Garfield S, Castaneda Y, Hughbanks-Wheaton D, Uauy R, Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev 2007;83:279-84.
154. Birch EE, Carlson SE, Hoffman DR, Fitzgerald-Gustafson KM, Fu VL, Drover JR, Castaneda YS, Minns L, Wheaton DK, Mundy D, Marunycz J, Diersen-Schade DA. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010;91:848-59.
155. Bouwstra H, Dijck-Brouwer J, Decsi T, Boehm G, Boersma ER, Muskiet FA, Hadders-Algra M. Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical transfatty acids. Pediatr Res 2006;60:334-9.
156. Eilander A, Hundscheid DC, Osendarp SJ, Transler C, Zock PL. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids 2007;76:189-203.
157. Transler C, Eilander A, Mitchell S, van de Meer N. The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders. J Atten Disord 2010;14:232-46.
158. Vecka M, Richterova B, Zak A, Tvrzicka E, Sramkova P, Stankova B, Klimcakova E, Stich V. Changes in serum and adipose tissue fatty acid composition after low calorie diet with respect to dietary fat content in obese. Cas Les Cesk 2006;145:464-9.
159. Hlavaty P, Kunesova M, Gojova M, Tvrzicka E, Vecka M, Roubal P, Hill M, Hlavata K, Kalouskova P, Hainer V, Zak A, Drbohlav J. Change in fatty acid composition of serum lipids in obese females after short-term weight-reducing regimen with the addition of n-3 long chain polyunsaturated fatty acids in comparison to controls. Physiol Res 2008;57:S57-S65.
160. Kunesova M, Braunerova R, Hlavaty P, Tvrzicka E, Stankova B, Skrha J, Hilgertova J, Hill M, Kopecky J, Wagenknecht M, Hainer V, Matoulek M, Parizkova J, Zak A, Svacina S. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 2006;55:63-72.
161. Asp ML, Collene AL, Norris LE, Cole RM, Stout MB, Tang SY, Hsu JC, Belury MA. Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: A randomized, double-masked, crossover study. Clin Nutr 2011; Epub ahead of print: (doi) 10.1016/j.clnu.2011.01.001.
162. Teng KT, Nagapan G, Cheng HM, Nesaretnam K. Palm Olein and Olive Oil Cause a Higher Increase in Postprandial Lipemia Compared with Lard but Had No Effect on Plasma Glucose, Insulin and Adipocytokines. Lipids 2011; Epub ahead of print: (doi) 10.1007/s11745-010-3516-y.
163. Teng KT, Voon PT, Cheng HM, Nesaretnam K. Effects of partially hydrogenated, semi-saturated, and high oleate vegetable oils on inflammatory arkers and lipids. Lipids 2010;45:385-92.
164. Gillingham LG, Gustafson JA, Han SY, Jassal DS, Jones PJ. Higholeic rapeseed (canola) and flaxseed oils modulate serum lipids and inflammatory biomarkers in hypercholesterolaemic subjects. Br J Nutr 2011;105:417-27.
165. Kwak JH, Paik JK, Kim OY, Jang Y, Lee SH, Ordovas JM, Lee JH. FADS gene polymorphisms in Koreans: association with omega6 polyunsaturated fatty acids in serum phospholipids, lipid peroxides, and coronary artery disease. Atherosclerosis 2011;214:94-100.
166. Lu Y, Feskens EJ, Dolle ME, Imholz S, Verschuren WM, Muller M, Boer JM. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL- cholesterol concentrations in the Doetinchem Cohort Study. Am J Clin Nutr 2010;92:258-65.
167. Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E, Sandri M, Friso S, Pizzolo F, Schaeffer L, Heinrich J, Pignatti PF, Corrocher R, Olivieri O. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008;88:941-9.
168. Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, Biscuola M, Cavallari U, Galavotti R, Martinelli N, Guarini P, Girelli D, Olivieri O, Corrocher R, Heinrich J, Pignatti PF, Illig T. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008;43:289-99.
169. Schaeffer L, Gohlke H, Muller M, Heid IM, Palmer LJ, Kompauer I, Demmelmair H, Illig T, Koletzko B, Heinrich J. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006;15:1745-56.
170. Park JY, Paik JK, Kim OY, Chae JS, Jang Y, Lee JH. Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on omega6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease. J Lipid Res 2010;51:3281-8.
171. Simopoulos AP. Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp Biol Med (Maywood) 2010;235:785-95.
172. Glaser C, Heinrich J, Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism 2010;59:993-9.
173. Zak A, Vecka M, Tvrzicka E, Hruby M, Novak F, Papezova H, Lubanda H, Vesela L, Stankova B. Composition of plasma fatty acids and non-cholesterol sterols in anorexia nervosa. Physiol Res 2005;54:443-51.
174. Zak A, Jachymova M, Tvrzicka E, Vecka M, Duffkova L, Zeman M, Slaby A, Stankova B. The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress. J Nutr Biochem 2008;19:634-41.
175. Zeman M, Vecka M, Jachymova M, Jirak R, Tvrzicka E, Stankova B, Zak A. Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression. Tohoku J Exp Med 2009;217:287-93.
176. Brenner RR. Factors influencing Fatty Acid Chain Elongation and Desaturation. In: Vergroesen AJ, Crawford M, editors. The role of fats in human nutrition. London: Academic Press; 1989. p. 45-79.
177. Burr GO, Burr MM. Nutrition classics from The Journal of Biological Chemistry 82:345-67, 1929.
178. Burr GO, Burr MM. A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr Rev 1973;31:248-9.
179. Crawford MA, Doyle W, Williams G, Drury PJ. The role of fats and EFAs for energy and cell structures in the growth of fetus and neonate. In: Vergroesen AJ, Crawford M, editors. The role of fats in human nutrition. London: Academic Press; 1989. p. 82-116.
180. Kinsella JE, Broughton KS, Whelan JW. Dietary unsaturated fatty acids: interactions and possible needs in relation to eicosanoid synthesis. J Nutr Biochem 1990;1:123-41.
181. Seo T, Blaner WS, Deckelbaum RJ. Omega-3 fatty acids: molecular approaches to optimal biological outcomes. Curr Opin Lipidol 2005;16:11-8.
182. Mead JF. The metabolism of polyunsaturated fatty acids. In: Holman RT, editor. Progress in the Chemistry of Fats and other Lipids. Oxford: Pergamon Press; 1971. p. 161-189.
183. Mead JF. The metabolism of the essential fatty acids. Am J Clin Nutr 1958; 6:656-61.
184. Dyerberg J. Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr Rev 1986;44:125-34.
185. Feskens EJ, Virtanen SM, Rasanen L, Tuomilehto J, Stengard J, Pekkanen J, Nissinen A, Kromhout D. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 1995;18:1104-12.
186. Holman RT, Johnson SB, Hatch TF. A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr 1982;35:617-23.
187. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, Van HC, Wennberg AK, Nelson JL, Noursalehi M. Effect of enteral feeding with eicosapentaenoic acid, gammalinolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999;27:1409-20.
188. Martinez M. The fundamentals and practice of docosahexaenoic acid therapy in peroxisomal disorders. Current Opinion in Clinical Nutrition & Metabolic Care 2000;3:101-8.
189. Oberkofler H, Liu YM, Esterbauer H, Hell E, Krempler F, Patsch W. Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans. Diabetologia 1998;41:940-6.
190. Zak A, Tvrzicka E, Vecka M, Jachymova M, Duffkova L, Stankova B, Vavrova L, Kodydkova J, Zeman M. Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men. Tohoku J Exp Med 2007;212:359-71.
191. Astrup A, Dyerberg J, Elwood P, Hermansen K, Hu FB, Jakobsen MU, Kok FJ, Krauss RM, Lecerf JM, Legrand P, Nestel P, Riserus U, Sanders T, Sinclair A, Stender S, Tholstrup T, Willett W. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr 2011; Epub ahead of print: (doi) 10.3945/ ajcn.110.004622.
192. Bysted A, Holmer G, Lund P, Sandstrom B, Tholstrup T. Effect of dietary fatty acids on the postprandial fatty acid composition of triacylglycerol-rich lipoproteins in healthy male subjects. Eur J Clin Nutr 2005;59:24-34.
193. Tholstrup T, Samman S. Postprandial lipoprotein(a) is affected differently by specific individual dietary fatty acids in healthy young men. J Nutr 2004;134:2550-5.
194. Tholstrup T, Teng KT, Raff M. Dietary Cocoa Butter or Refined Olive Oil Does Not Alter Postprandial hsCRP and IL-6 Concentrations in Healthy Women. Lipids 2011; Epub ahead of print: (doi) 10.1007/s11745-011-3526-4.
195. Sanders TA, Oakley FR, Cooper JA, Miller GJ. Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects. Am J Clin Nutr 2001;73:715-21.
196. Tholstrup T, Vessby B, Sandstrom B. Difference in effect of myristic and stearic acid on plasma HDL cholesterol within 24 h in young men. Eur J Clin Nutr 2003;57:735-42.
197. Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009;63:5S-21S.
198. Tardy AL, Morio B, Chardigny JM, Malpuech-Brugere C. Ruminant and industrial sources of trans-fat and cardiovascular and diabetic diseases. Nutr Res Rev 2011; Epub ahead of print: (doi) 10.1017/S0954422411000011.
199. Adhikari P, Shin JA, Lee JH, Hu JN, Zhu XM, Akoh CC, Lee KT. Production of trans-free margarine stock by enzymatic interesterification of rice bran oil, palm stearin and coconut oil. J Sci Food Agric 2010;90:703-11.
200. Gillingham LG, Harris-Janz S, Jones PJ. Dietary Monounsaturated Fatty Acids Are Protective Against Metabolic Syndrome and Cardiovascular Disease Risk Factors. Lipids 2011; Epub ahead of print: (doi) 10.1007/s11745-010-3524-y.
201. Marchioli R, Barzi F, Bomba E, Chieffo C, Di GD, Di MR, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-903.
202. Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 2010;104:1586-600.
203. Singh RB, Dubnov G, Niaz MA, Ghosh S, Singh R, Rastogi SS, Manor O, Pella D, Berry EM. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised singleblind trial. Lancet 2002;360:1455-61.
204. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 1980;208:401-6.
205. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 1980;33:2657-61.
206. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebocontrolled trial. Lancet 2008;372:1223-30.
207. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, Grimble RF. Association of n-3 pol-yunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003; 361:477-85.
208. Amani R, Noorizadeh M, Rahmanian S, Afzali N, Haghighizadeh MH. Nutritional related cardiovascular risk factors in patients with coronary artery disease in Iran: a case-control study. Nutr J 2010;9:70.
209. Iso H. Lifestyle and Cardiovascular Disease in Japan. J Atheroscler Thromb 2011; Epub ahead of print: (doi) JST. JSTAGE/jat/6866.
210. Serhan CN, Gotlinger K, Hong S, Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 2004;73:155-72.
211. Yaqoob P, Calder PC. Fatty acids and immune function: new insights into mechanisms. Br J Nutr 2007;98:S41-S45.
212. Calder PC, Yaqoob P. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell Mol Biol 2010;56:28-37.
213. Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother 2008;9:1237-48.
214. Musa-Veloso K, Binns MA, Kocenas AC, Poon T, Elliot JA, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev 2010;68:155-67.
215. Zak A, Hrabak P, Zeman M. Treatment of severe hypertriglyceridemia with a combination of n-3 fatty acids and bezafibrate. In: Gotto AM, Mancini M, Richter WO, Schwandt P, editors. Treatment of severe dylipoproteinemia in the prevention of coronary heart disease - 3rd Int Symp Munich 1990. Basel: Karger;1992. p. 240-4.
216. Zeman M, Zak A, Vecka M, Tvrzicka E, Pisarikova A, Stankova B. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J Nut Biochem 2006;17:379-84.
217. de Lorgeril M, Salen P, Guiraud A, Zeghichi S, Boucher F, de Leiris J. Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease. Nutr Metab Cardiovasc Dis 2005;15:36-41.
218. Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005;165:725-30.
219. Manco M, Calvani M, Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab 2004;6:402-13.
220. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, McGarry JD. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997;100:398-403.
221. Montecucco F, Steffens S, Mach F. Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability. Mediators Inflamm 2008; (doi) 10.1155/2008/767623.
222. Lopez S, Bermudez B, Pacheco YM, Villar J, Abia R, Muriana FJ. Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr 2008;88:638-44.
223. Rojo-Martinez G, Esteva I, Ruiz de Adana MS, Garcia-Almeida JM, Tinahones F, Cardona F, Morcillo S, Garcia-Escobar E, Garcia-Fuentes E, Soriguer F. Dietary fatty acids and insulin secretion: a population-based study. Eur J Clin Nutr 2006;60:1195-200.
224. Cerf ME. High fat diet modulation of glucose sensing in the betacell. Med Sci Monit 2007;13:RA12-RA17.
225. Martin de Santa OL, Sanchez Muniz FJ, Vaquero MP. N-3 fatty acids in glucose metabolism and insulin sensitivity. Nutr Hosp 2009;24:113-27.
226. Navas-Carretero S, Perez-Granados AM, Schoppen S, Vaquero MP. An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women. Br J Nutr 2009;102:546-53.
227. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999;70:817-25.
228. Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007;9:70-80.
229. Carroll KK. Dietary fat and cancer: specific action or caloric effect? J Nutr 1986;116:1130-2.
230. Costa I, Moral R, Solanas M, Andreu FJ, Ruiz de Villa MC, Escrich E. High corn oil and extra virgin olive oil diets and experimental mammary carcinogenesis: clinicopathological and immunohistochemical p21Ha-Ras expression study. Virchows Arch 2011;458:141-51.
231. Weisburger JH. Dietary fat and risk of chronic disease: mechanistic insights from experimental studies. J Am Diet Assoc 1997;97:16S-23S.
232. Stehr SN, Heller AR. Omega-3 fatty acid effects on biochemical indices following cancer surgery. Clin Chim Acta 2006;373:1-8.
233. Berquin IM, Edwards IJ, Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 2008;269:363-77.
234. Kalapothaki V, Tzonou A, Hsieh CC, Karakatsani A, Trichopoulou A, Toupadaki N, Trichopoulos D. Nutrient intake and cancer of the pancreas: a case-control study in Athens, Greece. Cancer Causes Control 1993;4:383-9.
235. Zhang J, Dhakal IB, Gross MD, Lang NP, Kadlubar FF, Harnack LJ, Anderson KE. Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota. Nutr Cancer 2009;61:457-65.
236. Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer 1991;47:1-6.
237. Brown TT, Zelnik DL, Dobs AS. Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients. Int J Gastrointest Cancer 2003;34:143-50.
238. Gong Z, Holly EA, Wang F, Chan JM, Bracci PM. Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer 2010;127:1893-904.
239. Boutros C, Somasundar P, Razzak A, Helton S, Espat NJ. Omega-3 fatty acids: investigations from cytokine regulation to pancreatic cancer gene suppression. Arch Surg 2010;145:515-20.
240. Kilian M, Gregor JI, Heukamp I, Wagner C, Walz MK, Schimke I, Kristiansen G, Wenger FA. Early inhibition of prostaglandin synthesis by n-3 fatty acids determinates histologic severity of necrotizing pancreatitis. Pancreas 2009;38:436-41.
241. Funahashi H, Satake M, Hasan S, Sawai H, Newman RA, Reber HA, Hines OJ, Eibl G. Opposing effects of n-6 and n-3 poly-unsaturated fatty acids on pancreatic cancer growth. Pancreas 2008;36:353-62.
242. Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, Zimmermann T, Koch T. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004;111:611-6.
243. Clarke SD. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 2004;15:13-8.
244. Kenler AS, Swails WS, Driscoll DF, DeMichele SJ, Daley B, Babineau TJ, Peterson MB, Bistrian BR. Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Ann Surg 1996;223:316-33.
245. Sala-Vila A, Barbosa VM, Calder PC. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care 2007;10:165-74.
246. Calder PC, Jensen GL, Koletzko BV, Singer P, Wanten GJ. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med 2010;36:735-49.
247. Mayer K, Seeger W. Fish oil-containing lipid emulsions in patients with sepsis. Crit Care 2010;14:128.
248. Novak F, Borovska J, Vecka M, Vavrova L, Kodydkova J, Mrackova M, Novak F, Sr., Novakova O, Zak A. Alterations in fatty acid composition of plasma and erythrocyte lipids in critically ill patients during sepsis. Cas Lek Cesk 2010;149:324-31.
249. Barbosa VM, Miles EA, Calhau C, Lafuente E, Calder PC. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010;14:R5.
250. Ferdinandusse S, Denis S, Mooijer PA, Zhang Z, Reddy JK, Spector AA, Wanders RJ. Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J Lipid Res 2001;42:1987-95.
251. Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, Garcia-Peris P, Garcia-de-Lorenzo A, Zarazaga A, Quecedo L, del LJ, Usan L, Casimiro C. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 2007;97:823-31.
252. Smith HJ, Greenberg NA, Tisdale MJ. Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice. Br J Cancer 2004;91:408-12.
253. Adam O, Beringer C, Kless T, Lemmen C, Adam A, Wiseman M, Adam P, Klimmek R, Forth W. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int 2003;23:27-36.
254. Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 2000; 27:2343-6.
255. Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, Stocker RP, Parhami N, Greenstein NS, Fuchs BR. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates. Arthritis Rheum 1995;38:1107-14.
256. Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 1992;87:432-7.
257. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease-a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med 1989;731:S225-S232.
258. Nordvik I, Myhr KM, Nyland H, Bjerve KS. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 2000; 102:143-9.
259. Duffy EM, Meenagh GK, McMillan SA, Strain JJ, Hannigan BM, Bell AL. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol 2004;31:1551-61.
260. Ilowite NT, Copperman N, Leicht T, Kwong T, Jacobson MS. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus. J Rheumatol 1995;22:1347-51.
261. Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur Respir J 1997;10:6-12.
262. Hodge L, Peat JK, Salome C. Increased consumption of polyun- saturated oils may be a cause of increased prevalence of childhood asthma. Aust N Z J Med1994;24:727.
263. Miles EA, Aston L, Calder PC. In vitro effects of eicosanoids derived from different 20-carbon fatty acids on T helper type 1 and T helper type 2 cytokine production in human whole-blood cultures. Clin Exp Allergy 2003;33:624-32.
264. Roper RL, Phipps RP. Prostaglandin E2 regulation of the immune response. Adv Prostaglandin Thromboxane Leukot Res 1994;22:101-11.
265. Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 1988;43:84-92.
266. Kirsch CM, Payan DG, Wong MY, Dohlman JG, Blake VA, Petri MA, Offenberger J, Goetzl EJ, Gold WM. Effect of eicosapentaenoic acid in asthma. Clin Allergy 1988;18:177-87.
267. Payan DG, Wong MY, Chernov-Rogan T, Valone FH, Pickett WC, Blake VA, Gold WM, Goetzl EJ. Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol 1986;6:402-10.
268. Schachter HM, Reisman J, Tran K, Dales B, Kourad K, Barnes D, Sampson M, Morrison A, Gaboury I, Blackman J. Health effects of omega-3 fatty acids on asthma. Evid RepTechnol Assess 2004;91:1-7.
269. Woods RK, Thien FC, Abramson MJ. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev 2002;3:CD001283.